OH...I don't know....If PSTI thought their PLX-PAD was all that, why wouldn't they wait for CHA shares to appreciate on the massive upside the partnership enables? Sell high, like the twins.....or do they know something about CHA
Hello Straightshot, I have been thinking about the most recent news and I am inclined to agree with your views. So far neither Pluristem nor CHA have made any announcement indicating an end to their cooperation and as Saud has said the two companies appear to be well matched. Yesterday we had two news releases and I think they may be related. I would imagine that Pluristem will need additional funding for their expanded access program in the immediate future even though Mr Yanay has stated that he hopes that the FDA may allow Pluristem to be compensated for the costs of treatment within that program. Do you have any idea how long it would take for such compensation to be authorised? I have noticed that no specific numbers have been announced of patients who are expected to be treated as part of this program.
News 
Market Data 
Discover 
AI
